Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federico Mosna

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Leukemia Research|February 12, 2022
Venetoclax in combination with hypomethylating agents in previously untreated patients with acute myeloid leukemia ineligible for intensive treatment: a real-life multicenter experienceEleonora De Bellis, Silvia Imbergamo, Anna Candoni, et al.
Vaccine|March 23, 2010
IFN-gamma-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancerMatteo Martini, Maria Grazia Testi, Matteo Pasetto, et al.
Bone Marrow Transplantation|May 5, 2022
Neurological complications in adult allogeneic hematopoietic stem cell transplant patients: Incidence, characteristics and long-term follow-up in a multicenter seriesMichele Wieczorek, Sara Mariotto, Sergio Ferrari, et al.
Circulation Research|October 10, 2009
Progenitor cells from the explanted heart generate immunocompatible myocardium within the transplanted donor heartDavid A D'Alessandro, Jan Kajstura, Toru Hosoda, et al.
Blood|March 14, 2007
ERK1/2 phosphorylation is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemiaChiara Gregorj, Maria R Ricciardi, Maria T Petrucci, et al.
American Journal of Hematology|August 11, 2020
Nelarabine as salvage therapy and bridge to allogeneic stem cell transplant in 118 adult patients with relapsed/refractory T-cell acute lymphoblastic leukemia/lymphoma. A CAMPUS ALL studyAnna Candoni, Davide Lazzarotto, Felicetto Ferrara, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 2, 2018
A Comparison of the Conditioning Regimens BEAM and FEAM for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma: An Observational Study on 1038 Patients From Fondazione Italiana LinfomiJacopo Olivieri, Federico Mosna, Matteo Pelosini, et al.
Blood Advances|February 10, 2025
Posttransplant cyclophosphamide as GVHD prophylaxis in patients receiving mismatched unrelated HCT: the PHYLOS trialAnna Maria Raiola, Benedetto Bruno, Antonio Maria Risitano, et al.
Annals of Hematology|August 26, 2025
Pegaspargase administration and tolerability in patients aged 55 years or older with acute lymphoblastic leukemia treated with the LAL1913 program. A subanalysis of the Campus ALL groupDavide Lazzarotto, Anna Maria Testi, Matteo Fanin, et al.
Bone Marrow Transplantation|June 2, 2025
Outcomes of allogeneic stem cell transplant in adult Philadelphia negative acute lymphoblastic leukemia patients treated with the pediatric-inspired GIMEMA 1913 protocol. A Campus ALL studyGianluca Cavallaro, Davide Lazzarotto, Chiara Pavoni, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Leukemia Research|February 12, 2022
Venetoclax in combination with hypomethylating agents in previously untreated patients with acute myeloid leukemia ineligible for intensive treatment: a real-life multicenter experienceEleonora De Bellis, Silvia Imbergamo, Anna Candoni, et al.
Vaccine|March 23, 2010
IFN-gamma-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancerMatteo Martini, Maria Grazia Testi, Matteo Pasetto, et al.
Bone Marrow Transplantation|May 5, 2022
Neurological complications in adult allogeneic hematopoietic stem cell transplant patients: Incidence, characteristics and long-term follow-up in a multicenter seriesMichele Wieczorek, Sara Mariotto, Sergio Ferrari, et al.
Circulation Research|October 10, 2009
Progenitor cells from the explanted heart generate immunocompatible myocardium within the transplanted donor heartDavid A D'Alessandro, Jan Kajstura, Toru Hosoda, et al.
Blood|March 14, 2007
ERK1/2 phosphorylation is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemiaChiara Gregorj, Maria R Ricciardi, Maria T Petrucci, et al.
American Journal of Hematology|August 11, 2020
Nelarabine as salvage therapy and bridge to allogeneic stem cell transplant in 118 adult patients with relapsed/refractory T-cell acute lymphoblastic leukemia/lymphoma. A CAMPUS ALL studyAnna Candoni, Davide Lazzarotto, Felicetto Ferrara, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 2, 2018
A Comparison of the Conditioning Regimens BEAM and FEAM for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma: An Observational Study on 1038 Patients From Fondazione Italiana LinfomiJacopo Olivieri, Federico Mosna, Matteo Pelosini, et al.
Blood Advances|February 10, 2025
Posttransplant cyclophosphamide as GVHD prophylaxis in patients receiving mismatched unrelated HCT: the PHYLOS trialAnna Maria Raiola, Benedetto Bruno, Antonio Maria Risitano, et al.
Annals of Hematology|August 26, 2025
Pegaspargase administration and tolerability in patients aged 55 years or older with acute lymphoblastic leukemia treated with the LAL1913 program. A subanalysis of the Campus ALL groupDavide Lazzarotto, Anna Maria Testi, Matteo Fanin, et al.
Bone Marrow Transplantation|June 2, 2025
Outcomes of allogeneic stem cell transplant in adult Philadelphia negative acute lymphoblastic leukemia patients treated with the pediatric-inspired GIMEMA 1913 protocol. A Campus ALL studyGianluca Cavallaro, Davide Lazzarotto, Chiara Pavoni, et al.
Pageof 4